The Dawning of the Age of Nefarious strategic-culture.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from strategic-culture.org Daily Mail and Mail on Sunday newspapers.
Dr Reddy s labs, its subsidiaries announces filing application for REEQONUS™ (favipiravir) Tablets
Hyderabad, Dec 22 (UNI) Dr. Reddy’s Laboratories Limited, along with its subsidiaries together referred to as “Dr. Reddy’s”, Appili Therapeutics and Global Response Aid FZCO (GRA) on Tuesday announced that Dr. Reddy’s Canada has filed an application on behalf of the consortium for REEQONUS™ (favipiravir) Tablets.
The REEQONUS™ (favipiravir) Tablets was for the acute treatment of mild to moderate COVID-19 adult patients under Health Canada’s Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.
REEQONUS™ is also known as Avigan® (favipiravir) Tablets developed by FUJIFILM Toyama Chemical Company Limited, the Pharma Company said in a release here.